Scientists hunt for genetic clues to prevent MS drug side effects
NCT ID NCT01118130
Summary
This study aimed to understand why some people with Multiple Sclerosis (MS) develop liver problems when taking a common drug called beta-interferon. Researchers compared the genes of 300 MS patients who had liver injury with those who did not, using saliva samples. The goal was to find genetic markers that could one day help predict this risk before treatment starts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dalhousie MS Research Unit
Halifax, Nova Scotia, Canada
-
Hôpital Notre-Dame MS clinic
Montreal, Quebec, Canada
-
London Health Sciences Centre MS clinic
London, Ontario, Canada
-
MS Clinic UBC Hospital
Vancouver, British Columbia, V6T 2B5, Canada
-
Winnipeg Health Sciences Centre
Winnipeg, Manitoba, Canada
Conditions
Explore the condition pages connected to this study.